Stoke Therapeutics, Inc. company logo
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. (STOK) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$127.98M$63.46M-33.15%

Summary

Current Value
As of today, STOK annual cash & cash equivalents is $127.98M, down -33.15% on
Historical Performance
STOK annual cash & cash equivalents is down -11.67% over the past 3 years, and down -42.47% over the past 5 years
All-Time High Comparison
STOK annual cash & cash equivalents is currently -55.45% below its historical high of $287.31M set on
3-Year Low Comparison
STOK annual cash & cash equivalents is +12.70% above its 3-year low of $113.56M reached on an earlier date
Sector Comparison
STOK annual cash & cash equivalents is higher than 70.40% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

STOK Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$127.98M-33.1%-11.7%-42.5%+7022.0%
Quarterly Cash & Cash Equivalents$248.31M+3.8%-1.3%+29.7%
Price$30.58+242.8%+213.6%-47.5%
Annual Current Assets$232.76M+8.1%+1.5%+3.0%+10000.0%
Annual Total Liabilities$42.53M-38.2%+101.7%+1040.0%
Annual Working Capital$192.70M+4.4%-9.1%-13.2%+10000.0%
Annual Net Income-$88.98M+15.0%-3.7%-175.3%-1501.0%

Cash and Cash Equivalents Highs

STOK Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$191.44M-33.1%
5Y$287.31MN/A-55.5%
All$287.31M-55.5%

Cash and Cash Equivalents Lows

STOK Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$113.56MN/A+12.7%
5Y$113.56M+12.7%
All$1.80M+7022.0%

Cash and Cash Equivalents History

YearValueChange
$127.98M-33.1%
$191.44M+68.6%
$113.56M-21.6%
$144.90M-49.6%
YearValueChange
$287.31M+29.1%
$222.47M+111.1%
$105.40M+5,765.3%
$1.80M-

FAQ

  • What is the current annual cash & cash equivalents of STOK?

    As of today, STOK annual cash & cash equivalents is $127.98M

  • What is 1-year change in STOK annual cash & cash equivalents?

    STOK annual cash & cash equivalents is down -33.15% year-over-year

  • What is 3-year change in STOK annual cash & cash equivalents?

    STOK annual cash & cash equivalents is down -11.67% over the past 3 years

  • How far is STOK annual cash & cash equivalents from its all-time high?

    STOK annual cash & cash equivalents is currently -55.45% below its historical high of $287.31M set on December 31, 2020

  • How does STOK annual cash & cash equivalents rank versus sector peers?

    STOK annual cash & cash equivalents is higher than 70.40% of companies in Healthcare sector

  • When is STOK next annual earnings release?

    The next annual earnings release for STOK is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. STOK Official Website www.stoketherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1623526/000119312525264720/0001193125-25-264720-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1623526/000095017025041170/0000950170-25-041170-index.htm
  4. STOK Profile on Yahoo Finance finance.yahoo.com/quote/STOK
  5. STOK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/stok